Invesco Biotechnology & Genome ETF
PBE
#1831
ETF rank
$0.25 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
$82.06
Share price
-0.06%
Change (1 day)
16.90%
Change (1 year)

Invesco Biotechnology & Genome ETF - Holdings

Etf holdings as of December 3, 2025

Number of holdings: 31

Full holdings list

Weight %NameTickerShares Held
5.39%Alnylam Pharmaceuticals IncALNY29494
5.14%Amgen IncAMGN38293
5.05%Biogen IncBIIB72430
5.02%Illumina IncILMN101676
4.98%United Therapeutics CorpUTHR26838
4.93%Gilead Sciences IncGILD102236
4.72%Incyte CorpINCY120549
4.70%Regeneron Pharmaceuticals IncREGN16819
3.10%BioCryst Pharmaceuticals IncBCRX1022796
2.94%MannKind CorpMNKD1361734
2.92%ACADIA Pharmaceuticals IncACAD292289
2.90%Neurocrine Biosciences IncNBIX49456
2.83%Collegium Pharmaceutical IncCOLL153076
2.81%Ionis Pharmaceuticals IncIONS88967
2.81%Exelixis IncEXEL165342
2.76%Veracyte IncVCYT149587
2.71%Royalty Pharma PLCRPRX175741
2.71%Bio-Techne CorpTECH110028
2.68%Repligen CorpRGEN41766
2.67%QIAGEN NVQGEN147939.1353
2.67%Amicus Therapeutics IncFOLD706339
2.66%TG Therapeutics IncTGTX218099
2.66%Madrigal Pharmaceuticals IncMDGL11882
2.65%Catalyst Pharmaceuticals IncCPRX296898
2.65%Protagonist Therapeutics IncPTGX79664
2.64%BioMarin Pharmaceutical IncBMRN125869
2.59%Vericel CorpVCEL179673
2.58%Dynavax Technologies CorpDVAX609709
2.56%PTC Therapeutics IncPTCT87507
2.36%Halozyme Therapeutics IncHALO94401
0.23%CASH & EQUIVALENTSUSD585253.42